Chris Round is President of EMD Serono, leading the North American biopharmaceutical business across the U.S. and Canada
Chris is a recognized leader in the pharmaceutical industry with a wealth of strategic and operational achievements. His track record includes launch experience, business transformation from primary care to oncology, leadership of local and regional operations, as well as global responsibilities in executive leadership teams. Chris has been with the organization since 2017, previously serving as Head of International and Core Franchises, where he was responsible for our international business comprised of China, Asia Pacific, Europe, Middle East, Africa, Russia and Latin America, and also had global accountability for the Fertility and the Cardiovascular Metabolism & Endocrinology (CM&E) Franchises.
Chris brings 25 years of global pharmaceutical experience to this position, including 20 years at Merck & Co., Inc. Chris started his professional career in finance with PwC in the UK. He holds a BA in Economics and Accounting from Newcastle University in the United Kingdom.